Myriad Genetics
MYGNMyriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at Myriad Genetics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 10/11/2024 | Sell | Diaz, Paul J. | President and CEO | $22.9 | $343,950 |
| 9/11/2024 | Sell | Diaz, Paul J. | President and CEO | $26.7 | $400,800 |
| 9/11/2024 | Sell | Muzzey, Dale | Chief Scientific Officer | $26.2 | $54,961 |
| 9/9/2024 | Sell | Dreismann, Heinrich | Director | $27.1 | $270,520 |
| 9/3/2024 | Sell | Reitan, Colleen F. | Director | $27.9 | $1,285,851 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)